• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
HLVX

HLVX

HilleVax, Inc.

NASDAQHealthcareBiotechnologyUS

USD2.09

-0.01 (-0.48%)

Company Profile

CEO

Robert M. Hershberg

IPO Date

2022-04-29

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.09

Prev. Close

$2.10

Day Low

$2.09

Day High

$2.09

52W Low

$1.34

52W High

$2.17

Market Cap

$0.10B

Volume

2.80M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Insider Trades
FiledInsiderRoleTypeA/DSharesPrice
19 Sept 2025TAKEDA PHARMACEUTICAL CO LTD10 percent ownerU-TenderDisposed6,724,000$1.95
17 Sept 2025Frazier Life Sciences X, L.P.10 percent ownerU-Tender
Disposed
17,199
$1.95
17 Sept 2025HERSHBERG ROBERTdirector, officer: President and CEOU-TenderDisposed1,101,498$1.95
17 Sept 2025Cocero NanettedirectorU-TenderDisposed17,199$1.95
17 Sept 2025HILLEMAN JERYL LdirectorU-TenderDisposed59,224$1.95
17 Sept 2025Chu ShelleydirectorU-TenderDisposed17,199$1.95
17 Sept 2025Dubin GarydirectorU-TenderDisposed17,199$1.95
17 Sept 2025Kohli AdityadirectorU-TenderDisposed698,171$1.95
17 Sept 2025Gerberding Julie L.directorU-TenderDisposed59,224$1.95
17 Sept 2025Maltbie ShaneChief Financial OfficerU-TenderDisposed83,738$1.95